Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
Anthelmintic treatment in horses: the extra-label use of products and the danger of under-dosing.
Journal of the South African Veterinary Association    September 12, 2003   Volume 74, Issue 2 53-56 doi: 10.4102/jsava.v74i2.505
Matthee S.Anthelmintic products form the basis of helminth control practices on horse stud farms at present. Regular evaluation of the efficacy of these products is advisable, as it will provide information on the worm egg reappearance period and the resistance status in the worm population. The aim of this study was to evaluate the efficacy of doramectin, pyrantel pamoate, ivermectin and moxidectin on a Thoroughbred stud farm in the Western Cape Province, South Africa. The study also compared the anthelmintic efficacy of two moxidectin formulations administered at their recommended dosages (an injectab...
Risk factors for fecal shedding of Salmonella from horses in a veterinary teaching hospital.
Preventive veterinary medicine    August 28, 2003   Volume 60, Issue 4 307-317 doi: 10.1016/s0167-5877(03)00143-0
Alinovi CA, Ward MP, Couëtil LL, Wu CC.Identification of risk factors for horses shedding Salmonella in their feces helps identify patients at-risk of infection and protect the overall population through heightened biosecurity. Fecal samples from 230 hospitalized horses were cultured for Salmonella spp. Historical data were collected on 21 putative risk factors and assessed for association with the risk of a horse being culture positive using forwards stepwise logistic regression. Salmonella was isolated from 13 horses--most commonly from either the first (n=5) or second (n=4) sample collected. Only presenting complaint (confounded...
APHIS: West Nile virus vaccine safe for use.
Journal of the American Veterinary Medical Association    August 22, 2003   Volume 223, Issue 4 416-418 
Kahler SC.No abstract available
Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
Vaccine    August 19, 2003   Volume 21, Issue 25-26 3815-3825 doi: 10.1016/s0264-410x(03)00329-3
Lopez AM, Hines MT, Palmer GH, Knowles DP, Alperin DC, Hines SA.Rhodococcus equi remains one of the most important pathogens of early life in horses, yet conventional vaccines to prevent rhodococcal pneumonia have not been successful. DNA vaccination offers an alternative to conventional vaccines with specific advantages for immunization of neonates. We developed a DNA vaccine expressing the vapA gene (pVR1055vapA) that induced an anamnestic response characterized by virulence associated protein A (VapA)-specific IgG antibodies in sera and bronchoalveolar lavage fluid (BALF) as well as VapA-specific proliferation of pulmonary lymphocytes when tested in adu...
Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic: a randomised double-blind clinical trial.
Equine veterinary journal    July 24, 2003   Volume 35, Issue 5 506-513 doi: 10.2746/042516403775600514
Feige K, Schwarzwald CC, Bombeli T.Unfractioned heparin (UFH) is widely used for prophylaxis of coagulation disorders, especially in colic-affected horses. However, it is accompanied by certain side effects. Objective: To compare the efficacy and side effects of unfractioned and low molecular weight heparin (LMWH) in horses with colic. Methods: The study was carried out as a randomised, double-blind, controlled clinical trial. Fifty-two horses with colic were treated subcutaneously with either UFH (heparin calcium, 150 iu/kg bwt initially, followed by 125 iu/kg bwt q. 12 h for 3 days and then 100 iu/kg bwt q. 12 h) or LMWH (dal...
Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines.
Equine veterinary journal    July 24, 2003   Volume 35, Issue 5 458-462 doi: 10.2746/042516403775600433
Daly JM, Yates RJ, Browse G, Swann Z, Newton JR, Jessett D, Davis-Poynter N, Mumford JA.Vaccination and challenge studies in ponies are the most relevant experimental system for predicting whether strains included in equine influenza vaccines are relevant, but they are difficult to perform. Objective: In order to investigate the feasibility of using a small animal model, results of a cross-protection study in hamsters were compared with those from a previous pony challenge experiment. Methods: Animals were immunised with inactivated vaccines containing one of 4 strains of equine influenza A H3N8 subtype virus isolated over a 26 year period (1963 to 1989), then challenged with a 1...
Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.
Journal of virology    July 15, 2003   Volume 77, Issue 15 8470-8480 doi: 10.1128/jvi.77.15.8470-8480.2003
Castillo-Olivares J, Wieringa R, Bakonyi T, de Vries AA, Davis-Poynter NJ, Rottier PJ.Equine arteritis virus (EAV) is an enveloped plus-strand RNA virus of the family Arteriviridae (order Nidovirales) that causes respiratory and reproductive disease in equids. Protective, virus-neutralizing antibodies (VNAb) elicited by infection are directed predominantly against an immunodominant region in the membrane-proximal domain of the viral envelope glycoprotein G(L), allowing recently the establishment of a sensitive peptide enzyme-linked immunosorbent assay (ELISA) based on this particular domain (J. Nugent et al., J. Virol. Methods 90:167-183, 2000). By using an infectious cDNA we h...
[The doping investigation in horses and the role of the treating veterinarian].
Tijdschrift voor diergeneeskunde    July 4, 2003   Volume 128, Issue 12 382 
Breukink HJ.No abstract available
Waste management: equine carcass disposal.
Journal of the American Veterinary Medical Association    July 4, 2003   Volume 223, Issue 1 48-49 doi: 10.2460/javma.2003.223.48
Haskell SR, Ormond CJ.No abstract available
Lords raise concerns over equine passports.
The Veterinary record    July 2, 2003   Volume 152, Issue 24 726 
No abstract available
A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.
Journal of virology    June 14, 2003   Volume 77, Issue 13 7244-7253 doi: 10.1128/jvi.77.13.7244-7253.2003
Li F, Craigo JK, Howe L, Steckbeck JD, Cook S, Issel C, Montelaro RC.Previous evaluations of inactivated whole-virus and envelope subunit vaccines to equine infectious anemia virus (EIAV) have revealed a broad spectrum of efficacy ranging from highly type-specific protection to severe enhancement of viral replication and disease in experimentally immunized equids. Among experimental animal lentivirus vaccines, immunizations with live attenuated viral strains have proven most effective, but the vaccine efficacy has been shown to be highly dependent on the nature and severity of the vaccine virus attenuation. We describe here for the first time the characterizati...
Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response.
Vaccine    June 12, 2003   Volume 21, Issue 21-22 3081-3092 doi: 10.1016/s0264-410x(03)00161-0
Soboll G, Nelson KM, Leuthner ES, Clark RJ, Drape R, Macklin MD, Swain WF, Olsen CW, Lunn DP.We have previously demonstrated that equine influenza virus hemagglutinin (HA) DNA vaccination protects ponies from challenge infection, and induces protective IgGa and IgGb responses. However, this approach does not induce a nasal IgA response. The objective of this study was to examine the value of cholera toxin (CT) administration as an adjuvant for intranasal HA DNA vaccination, and to measure protection 3 months after DNA vaccination. After an immunogenic dose of CT was determined, ponies were immunized on two occasions by intranasal administration of HA DNA and cholera toxin, or HA DNA a...
Optimising vaccination strategies in equine influenza.
Vaccine    June 12, 2003   Volume 21, Issue 21-22 2862-2870 doi: 10.1016/s0264-410x(03)00156-7
Park AW, Wood JL, Newton JR, Daly J, Mumford JA, Grenfell BT.A stochastic model of equine influenza (EI) is constructed to assess the risk of an outbreak in a Thoroughbred population at a typical flat race training yard. The model is parameterised using data from equine challenge experiments conducted by the Animal Health Trust (relating to the latent and infectious period of animals) and also published data on previous epidemics (to estimate the transmission rate for equine influenza). Using 89 ponies, an empirical relationship between pre-challenge antibody and the probability of becoming infectious is established using logistic regression. Changes in...
Testing for equine arteritis virus.
The Veterinary record    June 7, 2003   Volume 152, Issue 20 636 
Burr P, Snodgrass D.No abstract available
[A new product in the vaccination gap: the vector vaccine. Merial introduced an innovative influenza-tetanus vaccine for horses].
Tijdschrift voor diergeneeskunde    May 29, 2003   Volume 128, Issue 9 295-296 
Hulsen J.No abstract available
A practical approach to anthelmintic resistance.
Equine veterinary journal    May 21, 2003   Volume 35, Issue 3 218-219 doi: 10.2746/042516403776148174
Sangster N.No abstract available
Cutaneous leishmaniosis in three horses in Spain.
Equine veterinary journal    May 21, 2003   Volume 35, Issue 3 320-323 doi: 10.2746/042516403776148336
Solano-Gallego L, Fernández-Bellon H, Serra R, Gállego M, Ramis A, Fondevila D, Ferrer L.No abstract available
Guidelines for surveillance, prevention and control of West Nile virus.
Epidemiological bulletin    May 21, 2003   Volume 23, Issue 4 12-14 
No abstract available
Increases in cytokine and antimicrobial peptide gene expression in horses by immunomodulation with Propionibacterium acnes.
Veterinary therapeutics : research in applied veterinary medicine    May 21, 2003   Volume 4, Issue 1 5-11 
Davis EG, Rush BR, Blecha F.Immunomodulation with Propionibacterium acnes is used for prophylaxis of respiratory disease or in horses suffering from chronic pulmonary inflammation; however, the mechanism for this response is poorly understood. Semiquantitative reverse transcriptase-polymerase chain reaction assays were used to evaluate gene expression of interleukin (IL)-2, IL-10, interferon (IFN)-gamma, and NK-lysin in healthy horses treated with P. acnes. Findings in the study indicated that horses treated with a P. acnes-based immunomodulator exhibited increased IFN-gamma and NK-lysin gene expression in peripheral blo...
Molecular studies on Babesia, Theileria and Hepatozoon in southern Europe. Part I. Epizootiological aspects.
Veterinary parasitology    April 30, 2003   Volume 113, Issue 3-4 189-201 doi: 10.1016/s0304-4017(03)00078-5
Criado-Fornelio A, Martinez-Marcos A, Buling-Saraña A, Barba-Carretero JC.Molecular epizootiology of piroplasmids (Babesia spp., Theileria spp.) and Hepatozoon canis was studied in mammals from southern Europe (mainly from Spain, but also from Portugal and France). Partial amplification and sequencing of the 18s rRNA gene was used for molecular diagnosis. In some particular cases (B. ovis and B. bovis) the complete 18s rRNA gene was sequenced. Blood samples were taken from domestic animals showing clinical symptoms: 10 dogs, 10 horses, 10 cows, 9 sheep and 1 goat. In addition, DNA samples were isolated from blood of 12 healthy dogs and from spleen of 10 wild red fox...
Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety.
The Canadian veterinary journal = La revue veterinaire canadienne    April 29, 2003   Volume 44, Issue 4 299-302 
Weese JS, Anderson ME, Lowe A, Monteith GJ.This study was designed to evaluate whether Lactobacillus rhamnosus strain GG (LGG), an extensively studied probiotic organism in humans, can colonize the intestines of adult horses and foals. Lactobacillus rhamnosus strain GG was administered to adult horses at doses of 1 x 10(9) CFU/50kg bodyweight (BW)/day (group 1, 7 horses), 1 x 10(10) colony forming units/ 50kg BW/day (group 2, 7 horses) and 5 x 10(10) colony forming units/50kg BW/day (group 3, 7 horses) for 5 d. Foals received 2 x 10(10) colony forming units/50kg BW/day (group 1, 7 foals) or 1 x 10(11) colony forming units/50kg BW/day (...
[The ‘Veterinary Information Point’, questions about export problems of horses].
Tijdschrift voor diergeneeskunde    April 18, 2003   Volume 128, Issue 7 219 
van Herten J.No abstract available
Efforts to pre-empt an equine influenza epidemic.
The Veterinary record    April 17, 2003   Volume 152, Issue 13 405-406 
Mumford J, Cardwell J, Daly J, Newton R.No abstract available
Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals.
Journal of the American Veterinary Medical Association    April 12, 2003   Volume 220, Issue 1 59-63 doi: 10.2460/javma.2002.220.59
Giguère S, Gaskin JM, Miller C, Bowman JL.To determine efficacy of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. Methods: Randomized clinical trial. Methods: 165 foals. Methods: Foals were randomly assigned to 1 of 2 groups (hyperimmune plasma or nontreated controls). Foals with failure of passive transfer (FPT) of immunity were treated with hyperimmune plasma and evaluated as a third group. Foals that received plasma were given 950 ml between 1 and 10 days of age and between 30 and 50 days of age. A tracheobronchial aspirate was obtained from fo...
Cutaneous and ocular habronemiasis in horses: 63 cases (1988-2002).
Journal of the American Veterinary Medical Association    April 11, 2003   Volume 222, Issue 7 978-982 doi: 10.2460/javma.2003.222.978
Pusterla N, Watson JL, Wilson WD, Affolter VK, Spier SJ.To describe clinical manifestations of cutaneous and ocular habronemiasis in horses and evaluate outcome of treatment. Methods: Retrospective study. Methods: 63 horses. Methods: The diagnosis was made on the basis of history, clinical signs, and identification of calcified concretions (sulfur granules) in lesions. Histologic examination of biopsy specimens was used to confirm the diagnosis. Case horses were compared with a control population of 12,720 horses examined during the same period. Results: Arabians, gray horses, and horses with diluted coat colors were overrepresented; Thoroughbreds ...
Verocytotoxin-producing Escherichia coli infection and private farm visits.
The Veterinary record    April 8, 2003   Volume 152, Issue 12 365-366 doi: 10.1136/vr.152.12.365
Willshaw GA, Evans J, Cheasty T, Cummins A, Pritchard GC.No abstract available
Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
Developments in biologicals    April 8, 2003   Volume 111 171-180 
Lucken R, Daas A, Behr-Gross ME.The European Directorate for the Quality of Medicines (EDQM) has organised an international collaborative study, divided in two phases, aimed at producing and establishing a suitable reference serum for serological potency testing of clostridial vaccines for batch consistency demonstration. In phase 1 a series of pools produced from sera provided by each manufacturer and raised against the broadest range of antigens possible were blended to obtain TN titres which were representative of the range normally elicited by the vaccines under test. Detailed statistical analysis of the data was not pos...
Phenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesis.
Journal of bacteriology    April 3, 2003   Volume 185, Issue 8 2644-2652 doi: 10.1128/JB.185.8.2644-2652.2003
Ashour J, Hondalus MK.Rhodococcus equi is a facultative intracellular opportunistic pathogen of immunocompromised people and a major cause of pneumonia in young horses. An effective live attenuated vaccine would be extremely useful in the prevention of R. equi disease in horses. Toward that end, we have developed an efficient transposon mutagenesis system that makes use of a Himar1 minitransposon delivered by a conditionally replicating plasmid for construction of R. equi mutants. We show that Himar1 transposition in R. equi is random and needs no apparent consensus sequence beyond the required TA dinucleotide. The...
An introductory survey of helminth control practices in south africa and anthelmintic resistance on Thoroughbred stud farms in the Western Cape Province.
Journal of the South African Veterinary Association    April 1, 2003   Volume 73, Issue 4 195-200 doi: 10.4102/jsava.v73i4.586
Matthee S, Dreyer FH, Hoffmann WA, van Niekerk FE.Fifty-one per cent of 110 questionnaires, designed for obtaining information on helminth control practices and management on Thoroughbred stud farms in South Africa, were completed by farmers during 2000. The number of horses per farm included in the questionnaire survey ranged from 15 to 410. Foals, yearlings and adult horses were treated with anthelmintics at a mean of 7.3 +/- 3.0, 6.6 +/- 2.7 and 5.3 +/- 2.3 times per year, respectively. An average of 3.4 different drugs were used annually, with ivermectin being used bymost farmers during 1997-2000. On 43% of farms the weights of horses wer...
Evaluation of a stochastic Markov-chain model for the development of forelimb injuries in Thoroughbred racehorses.
American journal of veterinary research    March 29, 2003   Volume 64, Issue 3 328-337 doi: 10.2460/ajvr.2003.64.328
Hill AE, Carpenter TE, Gardner IA, Stover SM.To evaluate a Markov-chain model for the development of forelimb injuries in Thoroughbreds and to use the model to determine effects of reducing sprint distance on incidence of metacarpal condylar fracture (CDY) and severe suspensory apparatus injury (SSAI). Methods: Weekly exercise and injury data for 122 Thoroughbreds during racing or training. Methods: Weekly data were used to construct a Markov-chain model with 5 states (uninjured [UNINJ], palpable suspensory apparatus injury [PSAII, SSAI, CDY, and lost to follow-up [LOST]). Transition probabilities between UNINJ and PSAI were estimated as...
1 67 68 69 70 71 119